General and abdominal obesity and incident hypertension among people living with HIV on antiretroviral therapy
Bibliographic Data
Hypertension is highly prevalent among people living with HIV (PLWH). We sought to characterize the hypertension incidence among PLWH on antiretroviral therapy, focusing on the effect of change in general and abdominal obesity on hypertension during follow-up. This was a prospective analysis of 229 treated PLWH aged over 40 years without hypertension at baseline. Overall a median follow-up of 2.9 years, 26.2% PLWH developed hypertension. In multivariable models, compared to those without obesity measures at both baseline and follow-up visit, PLWH with general obesity at both occasions (adjusted odds ratio [aOR] = 3.83, P = 0.006) or at baseline only (aOR = 5.45, P = 0.003), abdominal obesity (measured as waist circumference) at both occasions (aOR = 3.87, P = 0.001) or at follow-up only (aOR = 2.27; 9P = 0.060), abdominal obesity (measured as waist-to-hip ratio) at both occasions (aOR = 2.27, P = 0.077) were at increased risk of incident hypertension. Our data show that both general and abdominal obesity especially in the persistent status increase the hypertension risk in treated PLWH
Abdominal obesity · Antiretroviral therapy · Body mass index · Obesity · Odds ratio · Prospective cohort study · Viral load · Waist · HIV-related health complications and treatments · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions · Medicine · Internal Medicine
Global Disparities of Hypertension Prevalence and Control
The interaction between detectable plasma viral load and increased body mass index on hypertension among persons living with HIV
Risk indicators and effects of hypertension on HIV/Aids disease progression among patients seen at Kenyatta hospital HIV care center
| Citation velocity | historical |
|---|---|
| Highly cited | No |